In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
Article Details
- CitationCopy to clipboard
Fass RJ, Helsel VL
In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
Diagn Microbiol Infect Dis. 1986 Jan;4(1):77-81.
- PubMed ID
- 3943292 [ View in PubMed]
- Abstract
The susceptibilities of 317 gram-negative bacilli to cefpiramide, cefotaxime, and piperacillin were determined by standardized microdilution and disk diffusion tests. Cefpiramide and piperacillin were more consistently active against nonfermenters than against Enterobacteriaceae, whereas cefotaxime was more active against Enterobacteriaceae. Inhibitory zone diameters of approximately 75-micrograms cefpiramide disks correlated well with minimal inhibitory concentrations (r = 0.85); breakpoints for defining susceptibility and resistance were recommended.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Cefpiramide D-alanyl-D-alanine carboxypeptidase DacC Protein Escherichia coli (strain K12) YesInhibitorDetails Cefpiramide Penicillin-binding protein 1A Protein Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228) YesInhibitorDetails Cefpiramide Penicillin-binding protein 1A Protein Escherichia coli (strain K12) YesInhibitorDetails Cefpiramide Penicillin-binding protein 1B Protein Escherichia coli (strain K12) YesInhibitorDetails Cefpiramide Penicillin-binding protein 1B Protein Pseudomonas aeruginosa YesInhibitorDetails Cefpiramide Peptidoglycan synthase FtsI Protein Escherichia coli (strain K12) YesInhibitorDetails